[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy].

IF 0.7 Q4 HEALTH POLICY & SERVICES

Farmaceuticos Comunitarios Pub Date : 2025-10-13 eCollection Date: 2025-10-15 DOI:10.33620/FC.2173-9218.(2025).33

G M Delgado-Pérez, X N Munayco Ortiz, J R Chipana Lujan, C E Dávila-Espinoza, V R Pizarro-Herrera

{"title":"[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy].","authors":"G M Delgado-Pérez, X N Munayco Ortiz, J R Chipana Lujan, C E Dávila-Espinoza, V R Pizarro-Herrera","doi":"10.33620/FC.2173-9218.(2025).33","DOIUrl":null,"url":null,"abstract":"Introduction: Pharmaceutical interventions (PI) are important for the resolution of drug-related problems (DRP). An alternative to efficiently meet this need is telepharmacy, defined as a modality of pharmaceutical services provided remotely through information and communication technologies (ICT).Objectives: To evaluate PI through telepharmacy in terms of their benefit to treatment effectiveness and/or safety.Methods: Retrospective observational study. Data were obtained from the pharmacotherapeutic records of eight community pharmacies that carried out PI through telepharmacy from November 2020 to October 2021. PI were evaluated using impact codes (benefit to treatment effectiveness and/or safety).Results: A total of 21 patients participated, of whom 11 were men. The median age was 61 years (Q1-Q3: 55-67). According to the ATC code, the most prevalent drug groups were: A-Alimentary tract and metabolism (n=38; 24.2%) and C-Cardiovascular system (n=31; 19.8%). A total of 183 DRP were identified (90 potential and 93 real) and 121 PI, of which 51.2% could be evaluated (n=62; 44 PI on effectiveness and 18 PI on safety).Conclusion: The PI carried out by community pharmacists were assessable and improved both the effectiveness and safety of medications.","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 4","pages":"94-116"},"PeriodicalIF":0.7000,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537052/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmaceuticos Comunitarios","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33620/FC.2173-9218.(2025).33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/15 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Pharmaceutical interventions (PI) are important for the resolution of drug-related problems (DRP). An alternative to efficiently meet this need is telepharmacy, defined as a modality of pharmaceutical services provided remotely through information and communication technologies (ICT).

Objectives: To evaluate PI through telepharmacy in terms of their benefit to treatment effectiveness and/or safety.

Methods: Retrospective observational study. Data were obtained from the pharmacotherapeutic records of eight community pharmacies that carried out PI through telepharmacy from November 2020 to October 2021. PI were evaluated using impact codes (benefit to treatment effectiveness and/or safety).

Results: A total of 21 patients participated, of whom 11 were men. The median age was 61 years (Q1-Q3: 55-67). According to the ATC code, the most prevalent drug groups were: A-Alimentary tract and metabolism (n=38; 24.2%) and C-Cardiovascular system (n=31; 19.8%). A total of 183 DRP were identified (90 potential and 93 real) and 121 PI, of which 51.2% could be evaluated (n=62; 44 PI on effectiveness and 18 PI on safety).

Conclusion: The PI carried out by community pharmacists were assessable and improved both the effectiveness and safety of medications.

查看原文本刊更多论文

[远程药房对社区患者药物干预的评价]。

药物干预（PI）是解决药物相关问题（DRP）的重要手段。有效满足这一需求的另一种选择是远程药房，它被定义为通过信息和通信技术（ICT）远程提供的一种药品服务方式。目的：评价远程药房的PI治疗效果和安全性。方法：回顾性观察研究。数据来自2020年11月至2021年10月通过远程药房开展PI的8家社区药房的药物治疗记录。使用影响码（对治疗有效性和/或安全性的益处）评估PI。结果：共21例患者参与，其中男性11例。中位年龄为61岁（Q1-Q3: 55-67岁）。根据ATC代码，最常见的药物组为：a -消化道和代谢系统（n=38, 24.2%）和c -心血管系统（n=31, 19.8%）。共鉴定出183个DRP（90个潜在DRP， 93个真实DRP）和121个PI，其中51.2%可评价（n=62；有效性DRP 44，安全性DRP 18）。结论：社区药师开展的PI可评估，提高了用药的有效性和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊